Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3, Open-Label Study Evaluating the Longterm Safety and Efficacy of VX-121 Combination Therapy in Subjects with Cystic Fibrosis
Wurth, Mark
(PI)
Anstead, Michael
(CoI)
Danov, Zoran
(Former PI)
Pediatrics
Overview
Grants and Contracts Details
Status
Active
Effective start/end date
6/16/22
→
4/3/25
Funding
Vertex Pharmaceuticals Inc:
$161,209.00
View all
View less